0
0
A recent study indicates that wearable technology, specifically smartwatches paired with health apps, could significantly aid individuals with type 2 diabetes (T2D) in adhering to exercise regimens crucial for managing their condition.
Researchers from Canada and the UK conducted a study, named MOTIVATE-T2D, focusing on newly diagnosed T2D patients participating in a home-based physical activity program. The study examined the impact of wearable technology on exercise adherence. The findings, published in BMJ Open, revealed that participants using smartwatches were more likely to initiate and maintain consistent exercise routines. The study successfully recruited 125 participants, achieving an impressive 82% retention rate over 12 months.
The research highlighted potential clinical benefits, including improvements in blood sugar levels and systolic blood pressure among participants utilizing wearable technology. Additionally, the program showed promise in lowering cholesterol levels and enhancing overall quality of life.
Dr. Katie Hesketh, co-author from the University of Birmingham, stated, “Our findings support the feasibility of the MOTIVATE-T2D intervention—paving the way for a full-scale randomized controlled trial to further investigate its clinical and cost-effectiveness. We found that using biometrics from wearable technologies offered great promise for encouraging people with newly diagnosed T2D to maintain a home-delivered, personalized exercise program with all the associated health benefits.”
The program involved participants gradually increasing moderate-to-vigorous intensity exercise, aiming for 150 minutes per week by the six-month mark. This was supported by virtual exercise specialist-led behavioral counseling. The wearable technology consisted of a smartwatch with a 3D accelerometer and optical heart rate monitor, synced with an online coaching platform for exercise specialists and a mobile app for participants.
“The program offered a variety of workouts, including cardio and strength training, that could be done without the need for a gym,” Dr. Hesketh added. “Its goal is to make exercise a sustainable part of daily life for people with type 2 diabetes, ultimately improving their physical and mental health.”
The feasibility trial included participants aged 40–75 years, diagnosed with T2D within the previous five to 24 months, and managing their condition through lifestyle modifications or Metformin.
Further research will be conducted to fully assess the clinical and cost-effectiveness of this intervention.
Disclaimer: This article is based on a single study and does not constitute medical advice. Consult with a healthcare professional before making any changes to your diabetes management or exercise routine. While the study shows promising results, further research is needed to confirm these findings and establish definitive clinical guidelines.
